{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:19:05Z","timestamp":1792095545741,"version":"4.4.0"},"reference-count":37,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To investigate the outcomes of primary photodynamic therapy (PDT) for pigmented posterior pole cT1a choroidal melanoma.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective interventional consecutive case series of 26 patients (26 eyes) with pigmented posterior pole cT1a choroidal melanoma, who were treated with 3 sessions of PDT and followed-up thereafter.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Included were 11 males and 15 females that presented at a median age of 66 years (mean: 64) with transformed naevi (n=11) or suspicious lesions (n=15) with \u22653\u2009risk factors for growth, with lipofuscin in all. In all cases, diagnosis was clinically based (no tissue biopsy). Tumour control was achieved in 16 (62%) patients in a median follow-up time of 29 months (mean: 27). Ten patients failed treatment by form of radial expansion, diagnosed in a median time of 13 months (mean: 12) from last treatment. By Kaplan-Meier analysis, success rate after 1, 2 and 3 years was 85%, 59% and 51%, respectively. On statistical analysis, number of suspicious features was found to be the only risk factor predicting failure (P=0.046). One patient developed macula-sparing branch retinal artery occlusion after treatment. Following PDT, subretinal fluid resolved in all cases and visual acuity significantly improved in all treatment-success cases (P=0.043). There were no cases of metastatic spread.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Primary PDT resulted in tumour regression of small, pigmented choroidal melanoma in 62% after a mean of 27 months. Treatment was more effective in tumours with three or less risk factors for growth, and resulted with fluid elimination and significant improvement in vision in treatment-success cases.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-311747","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T18:31:10Z","timestamp":1518546670000},"page":"1705-1710","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Primary photodynamic therapy with verteporfin for pigmented posterior pole cT1a choroidal melanoma: a 3-year retrospective analysis"],"prefix":"10.1136","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0846-5131","authenticated-orcid":false,"given":"Ido Didi","family":"Fabian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W","family":"Stacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamis Al","family":"Harby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit K","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep S","family":"Sagoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria M L","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"2020050713002003000_102.12.1705.1","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(88)90173-7"},{"key":"2020050713002003000_102.12.1705.2","unstructured":"Kivela T , Sampson ER , Grossniklauss HE , et al . In: Amin MB , Edge SB , Greene FL , eds. AJCC Cancer Staging Manual. 8th edn, 2017."},{"key":"2020050713002003000_102.12.1705.3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000334401","article-title":"Comparison of clinical outcomes for patients with large choroidal melanoma after primary treatment with enucleation or proton beam radiotherapy","volume":"227","author":"Mosci","year":"2012","journal-title":"Ophthalmologica"},{"key":"2020050713002003000_102.12.1705.4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000433546","article-title":"Outcomes of Proton Beam Radiotherapy for Large Non-Peripapillary Choroidal and Ciliary Body Melanoma at TRIUMF and the BC Cancer Agency","volume":"2","author":"Weber","year":"2015","journal-title":"Ocul Oncol Pathol"},{"key":"2020050713002003000_102.12.1705.5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ajo.2016.02.027","article-title":"Outcomes After Proton Beam Therapy for Large Choroidal Melanomas in 492 Patients","volume":"165","author":"Bensoussan","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"2020050713002003000_102.12.1705.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.08.046"},{"key":"2020050713002003000_102.12.1705.7","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.151"},{"key":"2020050713002003000_102.12.1705.8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ophtha.2016.12.026","article-title":"Cytogenetic Abnormalities in Uveal Melanoma Based on Tumor Features and Size in 1059 Patients: The 2016 W. Richard Green Lecture","volume":"124","author":"Shields","year":"2017","journal-title":"Ophthalmology"},{"key":"2020050713002003000_102.12.1705.9","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.208"},{"key":"2020050713002003000_102.12.1705.10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamaophthalmol.2014.111","article-title":"Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases","volume":"132","author":"Sagoo","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"2020050713002003000_102.12.1705.11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(14)72432-8","article-title":"Comparison of xenon arc and argon laser photocoagulation in the treatment of choroidal melanomas","volume":"109","author":"Shields","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"2020050713002003000_102.12.1705.12","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.133249"},{"key":"2020050713002003000_102.12.1705.13","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-304432"},{"key":"2020050713002003000_102.12.1705.14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pdpdt.2017.10.018","article-title":"Photodynamic therapy as initial treatment for small choroidal melanomas","volume":"20","author":"Jmor","year":"2017","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2020050713002003000_102.12.1705.15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/eye.2017.22","article-title":"Primary photodynamic therapy with verteporfin for small pigmented posterior pole choroidal melanoma","volume":"31","author":"Fabian","year":"2017","journal-title":"Eye"},{"key":"2020050713002003000_102.12.1705.16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archopht.118.3.360","article-title":"Combination of clinical factors predictive of growth of small choroidal melanocytic tumors","volume":"118","author":"Shields","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"2020050713002003000_102.12.1705.17","unstructured":"Core Team R. A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria: Core Team R, 2016."},{"key":"2020050713002003000_102.12.1705.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(98)00003-8"},{"key":"2020050713002003000_102.12.1705.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.06.007"},{"key":"2020050713002003000_102.12.1705.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90456-6"},{"key":"2020050713002003000_102.12.1705.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.01.016"},{"key":"2020050713002003000_102.12.1705.22","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-306921"},{"key":"2020050713002003000_102.12.1705.23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ajo.2015.11.005","article-title":"Fine Needle Aspiration Biopsy in Uveal Melanoma: Technique, Complications, and Outcomes","volume":"162","author":"Sellam","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"2020050713002003000_102.12.1705.24","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ejca.2015.07.013","article-title":"Uveal Melanoma UK National Guidelines","volume":"51","author":"Nathan","year":"2015","journal-title":"Eur J Cancer"},{"key":"2020050713002003000_102.12.1705.25","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070110084030"},{"key":"2020050713002003000_102.12.1705.26","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/IAE.10.1097\/IAE.0b013e31822c28ec","article-title":"Treatment of amelanotic choroidal melanoma with photodynamic therapy","volume":"32","author":"Campbell","year":"2012","journal-title":"Retina"},{"key":"2020050713002003000_102.12.1705.27","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.75.12.718"},{"key":"2020050713002003000_102.12.1705.28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/lsm.20186","article-title":"Photodynamic therapy of head and neck basal cell carcinoma according to different clinicopathologic features","volume":"36","author":"Kaviani","year":"2005","journal-title":"Lasers Surg Med"},{"key":"2020050713002003000_102.12.1705.29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008390-199510000-00009","article-title":"Photodynamic therapy: a 5-year study of its effectiveness in the treatment of posterior uveal melanoma, and evaluation of haematoporphyrin uptake and photocytotoxicity of melanoma cells in tissue culture","volume":"5","author":"Favilla","year":"1995","journal-title":"Melanoma Res"},{"key":"2020050713002003000_102.12.1705.30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.survophthal.2015.05.004","article-title":"Clinical use of photodynamic therapy in ocular tumors","volume":"60","author":"Cerman","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"2020050713002003000_102.12.1705.31","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3458"},{"key":"2020050713002003000_102.12.1705.32","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/IAE.0000000000001202","article-title":"PHOTODYNAMIC THERAPY FOR CHOROIDAL NEVUS WITH SUBFOVEAL FLUID","volume":"37","author":"Pointdujour-Lim","year":"2017","journal-title":"Retina"},{"key":"2020050713002003000_102.12.1705.33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.pdpdt.2013.07.004","article-title":"Branch retinal artery occlusion associated with photodynamic therapy in a circumscribed choroidal haemangioma","volume":"10","author":"Xiao","year":"2013","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"2020050713002003000_102.12.1705.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.05.033"},{"key":"2020050713002003000_102.12.1705.35","first-page":"e5","article-title":"[Cerebrovascular accident following photodynamic therapy]","volume":"30","author":"Quintyn","year":"2007","journal-title":"J Fr Ophtalmol"},{"key":"2020050713002003000_102.12.1705.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01475-7"},{"key":"2020050713002003000_102.12.1705.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00526-1"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-311747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:57:09Z","timestamp":1601110629000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-311747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,11,22]]},"published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1136\/bjophthalmol-2017-311747"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311747","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]}}}